IP Management/Tech Transfer Strategies for Improved Global Health.
Abstract
As well as giving a general description of the Medicines for Malaria Venture, this presentation describes how it deals with intellectual property issues; in general terms, it ensures that MMV has the intellectual property rights it needs to develop antimalarials and make them available in malaria-endemic regions, but no more than is necesary, with private sector partners retaining other rights.
Citation
Presentation from ‘PDPs and Alternative IP Management/Tech Transfer Strategies for Improved Global Health’. Symposium held at BIO 2009, Atlanta, USA, 20 May 2009.
Links